Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126259501 | 12625950 | 1 | I | 20151111 | 20160425 | 20160805 | 20160805 | EXP | PHHY2016PH058167 | NOVARTIS | 63.30 | YR | F | Y | 0.00000 | 20160805 | CN | COUNTRY NOT SPECIFIED | PH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126259501 | 12625950 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | Y | 22068 | 600 | MG | CAPSULE | QD | |||||
| 126259501 | 12625950 | 2 | SS | TASIGNA | NILOTINIB | 1 | Unknown | 2 CAP BID | Y | 22068 | CAPSULE | BID | |||||||
| 126259501 | 12625950 | 3 | C | ANAGRELIDE | ANAGRELIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126259501 | 12625950 | 1 | Chronic myeloid leukaemia |
| 126259501 | 12625950 | 3 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126259501 | 12625950 | HO |
| 126259501 | 12625950 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126259501 | 12625950 | Basophil count increased | |
| 126259501 | 12625950 | Chronic myeloid leukaemia | |
| 126259501 | 12625950 | Drug intolerance | |
| 126259501 | 12625950 | Erythromelalgia | |
| 126259501 | 12625950 | Haematocrit decreased | |
| 126259501 | 12625950 | Haemoglobin decreased | |
| 126259501 | 12625950 | Headache | |
| 126259501 | 12625950 | Lymphocyte count decreased | |
| 126259501 | 12625950 | Monocyte count decreased | |
| 126259501 | 12625950 | Myalgia | |
| 126259501 | 12625950 | Pain | |
| 126259501 | 12625950 | Pain in extremity | |
| 126259501 | 12625950 | Pain of skin | |
| 126259501 | 12625950 | Platelet count increased | |
| 126259501 | 12625950 | Red blood cell count decreased | |
| 126259501 | 12625950 | Red cell distribution width increased | |
| 126259501 | 12625950 | Thrombocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126259501 | 12625950 | 1 | 201507 | 201604 | 0 |